| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YRTPH.2018.07.006 |
| P698 | PubMed publication ID | 30009863 |
| P50 | author | Christopher J Bowman | Q72989354 |
| P2093 | author name string | LaRonda L Morford | |
| Joy Cavagnaro | |||
| Wendy G Halpern | |||
| Diann L Blanset | |||
| Meredith Rocca | |||
| P2860 | cites work | A comparison of effects on reproduction and neonatal development in cynomolgus monkeys given human soluble IL-4R and mice given murine soluble IL-4R. | Q51820841 |
| Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization. | Q52528591 | ||
| The preclinical development of Roferon-A. | Q53890139 | ||
| Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men | Q57322613 | ||
| Strain-dependent epithelial defects in mice lacking the EGF receptor | Q58326927 | ||
| Compensatory response of IL-1 gene knockout mice after pulmonary infection with Klebsiella pneumoniae | Q62735810 | ||
| The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs | Q73149177 | ||
| Marginal transfer of ReoPro (Abciximab) compared with immunoglobulin G (F105), inulin and water in the perfused human placenta in vitro | Q73642484 | ||
| Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (LANTUS) in rats and rabbits | Q74260762 | ||
| Phenotype of a calbindin-D9k gene knockout is compensated for by the induction of other calcium transporter genes in a mouse model | Q80792313 | ||
| Allelic variations of RANKL/OPG signaling system are related to bone mineral density and in vivo gene expression | Q84943063 | ||
| Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database | Q88289186 | ||
| Placental and Fetal Effects of Onartuzumab, a Met/HGF Signaling Antagonist, When Administered to Pregnant Cynomolgus Monkeys | Q89076171 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans | Q28208533 | ||
| Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype | Q28509173 | ||
| A specific requirement for PDGF-C in palate formation and PDGFR-alpha signaling | Q28585038 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| PDGFR-alpha signaling is critical for tooth cusp and palate morphogenesis | Q28592140 | ||
| Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune re | Q28594116 | ||
| A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor | Q33888193 | ||
| Amino acid transporters in the human placenta | Q34131329 | ||
| Placental transport of immunoglobulin G. | Q35172881 | ||
| Drug transfer and metabolism by the human placenta. | Q35788063 | ||
| Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets | Q36158922 | ||
| PDGFRa mutations in humans with isolated cleft palate. | Q36253455 | ||
| The PD-1-PD-L pathway in immunological tolerance | Q36405777 | ||
| An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies | Q37559465 | ||
| The placenta, transfer of immunoglobulins, and safety assessment of biopharmaceuticals in pregnancy. | Q37986126 | ||
| Contemporary uses of erythropoietin in pregnancy: a literature review | Q38127124 | ||
| An Evaluation of the Impact of PD-1 Pathway Blockade on Reproductive Safety of Therapeutic PD-1 Inhibitors | Q38803301 | ||
| Traversing barriers - How thyroid hormones pass placental, blood-brain and blood-cerebrospinal fluid barriers | Q39116461 | ||
| Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells | Q40826883 | ||
| Variation in transplacental transfer of tyrosine kinase inhibitors in the human perfused cotyledon model | Q41103420 | ||
| Reproductive toxicity of denosumab in cynomolgus monkeys | Q43568859 | ||
| Placental transfer of Fc-containing biopharmaceuticals across species, an industry survey analysis | Q43583667 | ||
| Effects of natalizumab, an alpha4 integrin inhibitor, on the development of Hartley guinea pigs | Q45166775 | ||
| Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men. | Q45298906 | ||
| Embryo/fetal development in cynomolgus monkeys exposed to natalizumab, an alpha4 integrin inhibitor. | Q46024688 | ||
| Comparative effects of interferon alpha-2b and pegylated interferon alpha-2b on menstrual cycles and ovarian hormones in cynomolgus monkeys | Q46109382 | ||
| Developmental Immunotoxicology Assessment of Rituximab in Cynomolgus Monkeys | Q46176587 | ||
| Perspective on a Modified Developmental and Reproductive Toxicity Testing Strategy for Cancer Immunotherapy | Q46608363 | ||
| Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor | Q46766121 | ||
| Teratogen-mediated inhibition of target tissue response to Shh signaling | Q48004971 | ||
| Regulatory T Cells Orchestrate Similar Immune Evasion of Fetuses and Tumors in Mice. | Q48093087 | ||
| Skeletal malformations in rat offspring. Long-term effect of maternal insulin-induced hypoglycemia during organogenesis. | Q50801299 | ||
| Investigation of maternal and fetal exposure to an IgG2 monoclonal antibody following biweekly intravaginal administration to cynomolgus monkeys throughout pregnancy. | Q51138447 | ||
| P304 | page(s) | 69-79 | |
| P577 | publication date | 2018-07-24 | |
| P1433 | published in | Regulatory Toxicology and Pharmacology | Q2138805 |
| P1476 | title | Applying a weight of evidence approach to the evaluation of developmental toxicity of biopharmaceuticals | |
| P478 | volume | 98 |
Search more.